Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Categories of Preference included for recommendations within NCCN Guidelines

The National Comprehensive Cancer Network has instituted Categories of Preference for recommendations within the NCCN Clinical Practice Guidelines in Oncology. Initially, Categories of Preference will be published for drugs and biologics recommended within the NCCN Guidelines® for Multiple Myeloma.

15 Sep 2017

Research finds link between caregiver’s gender, relationship and severity of child abuse injuries

Efforts to prevent child abuse by people who care for children should extend to additional categories of caregivers since injuries that children suffer at the hands of their parent's male partner, babysitter or daycare worker are likely to be more severe, according to research presented during the 2017 American Academy of Pediatrics national conference.

15 Sep 2017

New study identifies best operating room infection control procedures

While hospitals grapple with what operating room (OR) infection control procedures work best, a new study of Texas hospitals has determined two areas that stand out: mandating sterile operating conditions at or close to the wound itself; and tracking in-hospital outcomes on surgical site infections (SSIs) and sharing that information with surgeons and other OR staff.

14 Sep 2017

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos. But over the last several decades, other causes of the disease have emerged, including treatment with high-intensity therapeutic radiation and, more recently, an inherited genetic mutation.

14 Sep 2017

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.

14 Sep 2017

Combination treatment improves progression-free survival in patients with advanced urothelial cancer

Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet.

14 Sep 2017

Patients diagnosed with glioblastoma benefit from care at high-volume centers, study suggests

Patients diagnosed at high-volume centers are up to 40 percent more likely to receive treatment for glioblastoma, according to a study from researchers at the University of Illinois at Chicago.

14 Sep 2017

Fusion guided biopsy can help with accurate diagnosis of prostate cancer

There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It's called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.

14 Sep 2017

Combination immunotherapy shows better overall survival in kidney cancer patients

A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.

13 Sep 2017

MGH researchers identify potential strategy for improving efficacy of angiogenesis inhibitors

A Massachusetts General Hospital research team has identified a potential strategy for improving the efficacy of angiogenesis inhibitors, drugs that help fight cancer by blocking the formation of new blood vessels.

13 Sep 2017

Researchers develop fluorescent sensors for detecting, tracking GTP levels in living cells

For several decades, scientists have recognized the key role that a molecule known as GTP, one of the building blocks of RNA, plays in the development of cancer and other diseases.

13 Sep 2017

Epigenetic changes triggered by cigarette smoke may be earliest step in lung cancer development

Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called "epigenetic" changes in the cells consistent with the earliest steps toward lung cancer development.

12 Sep 2017

Australian researchers make ultimate move in the battle against melanoma

A team of Australian researchers has made the ultimate move in the battle to beat melanoma, successfully trialing a combination of new treatments to stop the disease in its tracks and prevent it from spreading or metastasizing to distant organs.

12 Sep 2017

Researchers identify protein that offers likely target for treating high-risk pediatric cancers

Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy--harnessing the immune system in medical treatments. In cell cultures and animal models, a potent drug attached to an antibody selectively zeroes in on cancer cells without harming healthy cells.

11 Sep 2017

Employer-related factors can help or hinder cancer survivors' return to work, analysis reveals

A new Psycho-Oncology analysis of published studies indicates that there are various employer-related factors that can help or hinder cancer survivors as they attempt to go back to work.

11 Sep 2017

Study identifies late effects that may interfere with work status of young adult cancer survivors

Factors that limit the work ability of young adult cancer survivors are reported today at the ESMO 2017 Congress in Madrid.

11 Sep 2017

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, is working to educate the public about hereditary cancer risk assessment and testing during Prostate Cancer Awareness Month this September.

11 Sep 2017

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage III BRAF-mutant melanoma, according to late-breaking results from the COMBI-AD trial presented today at the ESMO 2017 Congress in Madrid and published in the New England Journal of Medicine.

11 Sep 2017

Generation Genome: the UK’s genetics revolution?

The report set out the NHS’ intentions of routinizing whole genome sequencing. It is particularly focused towards rare diseases and cancers, although conditions such as obesity, bacterial and other infections are also included.

11 Sep 2017

Abdominal weight found to be key predictor of cancer risk in postmenopausal women

Body fat distribution in the trunk is more important than body weight when it comes to cancer risk in postmenopausal women, according to a study presented at the ESMO 2017 Congress in Madrid.

11 Sep 2017

Oncology News and Research

Further Reading

Categories of Preference included for recommendations within NCCN Guidelines

Research finds link between caregiver’s gender, relationship and severity of child abuse injuries

New study identifies best operating room infection control procedures

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

Combination treatment improves progression-free survival in patients with advanced urothelial cancer

Patients diagnosed with glioblastoma benefit from care at high-volume centers, study suggests

Fusion guided biopsy can help with accurate diagnosis of prostate cancer

Combination immunotherapy shows better overall survival in kidney cancer patients

MGH researchers identify potential strategy for improving efficacy of angiogenesis inhibitors

Researchers develop fluorescent sensors for detecting, tracking GTP levels in living cells

Epigenetic changes triggered by cigarette smoke may be earliest step in lung cancer development

Australian researchers make ultimate move in the battle against melanoma

Researchers identify protein that offers likely target for treating high-risk pediatric cancers

Employer-related factors can help or hinder cancer survivors' return to work, analysis reveals

Study identifies late effects that may interfere with work status of young adult cancer survivors

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Generation Genome: the UK’s genetics revolution?

Abdominal weight found to be key predictor of cancer risk in postmenopausal women

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News